Skip to main content

Find Clinical Trials

Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

NCT00978497

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: United States, California 1 Anaheim, California, United States

United States, California 4 Los Angeles, California, United States

United States, California 2 San Clemente, California, United States

United States, California 3 San Diego, California, United States

View all 21 locations

View Trial Details

Completed

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)

NCT01743521

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: St Vincent's Hospital Sydney, New South Wales, Australia

Royal Adelaide Hospital Adelaide, South Australia, Australia

View Trial Details

Completed

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

NCT00959933

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions

NCT00960479

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders

NCT00684268

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Medical University of Vienna Vienna, Austria

View Trial Details

Completed

The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital

NCT02904252

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +20 more
Locations: Faculty of Medicine Siriraj Hospital Bangkok, Thailand

View Trial Details

Completed

Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection

NCT00248339

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

NCT00252642

Conditions: Blood-Borne Infections, Cirrhosis, Communicable Diseases, +13 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants

NCT02268864

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Antwerp, Belgium

Brussels, Belgium

Ghent, Belgium

Créteil, France

View all 23 locations

View Trial Details

Completed

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

NCT01925183

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna Vienna, State of Vienna, Austria

View Trial Details